Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > Check out Sphinx Resources ticker SFX at .01 cent

<< Previous

Bullboard Posts

Next >>

Comment by Chritterson Jun 26, 2020 9:21am

80 Views

Post# 31194396

RE:Check out Sphinx Resources ticker SFX at .01 cent

Go away Pump your trash stock elsewhere!!

Lithiumjuniors wrote:
Management did a PP at .03 cents recently and it's at .01 cent now. You can buy and sell at .02 and double your money before management is even back to even on theirs.

They have a couple promising gold/copper projects in Quebec. They are going to announce drilling any day here soon so once that happens we can expect a promo and a run up. Management is going to want to get their .03 cent shares in the money. So this is a great opportunity to take advantage of.

Do your own DD and check them out.